CorMedix Inc Stock News

After losing some value lately, a hammer chart pattern has been formed for CorMedix (CRMD), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisi

BERKELEY HEIGHTS, N.J., March 21, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention a

BERKELEY HEIGHTS, N.J., Dec. 06, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention

Analysts say these are penny stocks to buy. Do you agree? The post 5 Penny Stocks To Buy According To Analysts, Targets Up To 353% appeared first on Penny Stocks to Buy, Picks, News and Information |

Analysts say these are penny stocks to buy. Do you agree?

CRMD earnings call for the period ending September 30, 2022.

CorMedix Inc. (NASDAQ:CRMD ) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Joe Todisco - Chief Executive Officer Matt David - Executive Vice President, Chief Finan

BERKELEY HEIGHTS, N.J. , Nov. 02, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention

BERKELEY HEIGHTS, N.J. , Nov. 02, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention a

CRMD earnings call for the period ending June 30, 2022.

CorMedix Inc. (NASDAQ:CRMD ) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Daniel Ferry - LifeSci Advisors, LLC Erin Mistry - Senior Vice President and Head, Payer S

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method. BBQ Holdings, Inc. (NAS

Bad news on the regulatory front leads investors to bail en masse from the company.

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 100 points on Tuesday. The Dow traded down 0.34% to 32,720.07 while the NASDAQ fell 1.38% to 12,470.08. The S&

Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for CO